INFRATIL LIMITED (IFT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IFT

IFT - INFRATIL LIMITED

Year End: March
GICS Industry Group : Capital Goods
Debt/EBITDA: 9.94
Index: ASX200 | ASX300 | ALL-ORDS

Infratil owns and develops infrastructure businesses across digital infrastructure, renewable energy, healthcare and airports.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$10.93

15 Sep
2026

-0.350

OPEN

$11.38

-3.10%

HIGH

$11.38

601,095

LOW

$10.91

TARGET
$14.49 32.6% upside
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CGF . DJW . GDG . GQG . HMC . HUB . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
IFT: 1
Title FY27
Forecast
FY28
Forecast
EPS (cps) 10.2 xxx
DPS (cps) 14.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 110.9 xxx
Dividend Yield 1.2% xxx
Div Pay Ratio(%) 136.7% xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 1.82%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.49

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/06 - (franking ex-div 9.51c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx49.6
DPS All xxxxxxxxxxxxxxx19.3
Sales/Revenue xxxxxxxxxxxxxxx2,617.4 M
Book Value Per Share xxxxxxxxxxxxxxx639.9
Net Operating Cash Flow xxxxxxxxxxxxxxx173.3 M
Net Profit Margin xxxxxxxxxxxxxxx9.15 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx3.85 %
Return on Invested Capital xxxxxxxxxxxxxxx1.96 %
Return on Assets xxxxxxxxxxxxxxx1.50 %
Return on Equity xxxxxxxxxxxxxxx3.85 %
Return on Total Capital xxxxxxxxxxxxxxx1.07 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-344.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx617 M
Long Term Debt xxxxxxxxxxxxxxx5,979 M
Total Debt xxxxxxxxxxxxxxx6,596 M
Goodwill - Gross xxxxxxxxxxxxxxx3,937 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx260 M
Price To Book Value xxxxxxxxxxxxxxx1.52

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx489.3 M
Capex % of Sales xxxxxxxxxxxxxxx18.69 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,819 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx651 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,494 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

27/05/2026

1

Buy

-

-

Infratil reported FY26 earnings and FY27 guidance in line with expectations. The share price fell -6% on the day. which UBS suggests was most likely due to some disappointment that there were no large contact signings for data centres (CDC)

UBS nevertheless expects new contract wins in the next six months and has reflected this partially in its CDC valuation uplift. As a result, the CDC valuation discount to NextDC ((NXT)) should close from -20% to below -10% or even parity, UBS believes.

Maintain Buy. Target rises to NZ$17.25 from NZ$16.50.

FORECAST
UBS forecasts a full year FY27 dividend of 17.72 cents.
UBS forecasts a full year FY28 dividend of 18.57 cents.

Morgans

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

15/09/2026

1

Buy

-

-

Jarden maintains a Buy rating for Infratil with its target price increased to NZ$18.63 from NZ$17.15 ahead of an upcoming investor update scheduled for 16 September.

Key focus areas across the portfolio presentation include asset sales, the strategic direction for One NZ, reasons behind stagnating independent valuations at Longroad, and ongoing capacity delivery from CDC.

Jarden also anticipates management commentary regarding a potential strategic shift by CDC towards establishing a data centre joint venture in New Zealand.

Jarden updates valuation models following recent independent asset appraisals, driving the revised net tangible asset-backed price target.

The analyst considers the company well leveraged to contracting momentum across CDC while maintaining long-term growth across key digital and renewable platforms.

IFT STOCK CHART